| P50 | author | Richard B. Lipton | Q56957375 |
| | David W Dodick | Q78768282 |
| | Stephen D. Silberstein | Q78771344 |
| P2093 | author name string | Stephen Silberstein | |
| | David Dodick | |
| | Roger Cady | |
| | Fred Freitag | |
| | Joseph Hulihan | |
| | Ninan Mathew | |
| | Steven Ascher | |
| | William H. Olson | |
| | David M. Biondi | |
| P2860 | cites work | Factors associated with the onset and remission of chronic daily headache in a population-based study | Q28212746 |
| | Incidence and predictors for chronicity of headache in patients with episodic migraine | Q28249010 |
| | Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability | Q33941878 |
| | Chronic daily headache | Q33952713 |
| | Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study | Q34216076 |
| | Chronic disorders with episodic manifestations: focus on epilepsy and migraine | Q34590975 |
| | The prognosis of migraine | Q34775422 |
| | Excessive acute migraine medication use and migraine progression | Q34887527 |
| | The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). | Q36261290 |
| | Lessons from placebo effects in migraine treatment | Q36332377 |
| | Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessons | Q36620663 |
| | Modifiable risk factors for migraine progression | Q36623145 |
| | Ten lessons on the epidemiology of migraine | Q36787439 |
| | Risk factors for headache chronification | Q37053918 |
| | Looking to the future: research designs for study of headache disease progression | Q37053932 |
| | Indirect cost burden of migraine in the United States | Q38463013 |
| | Placebo effect and clinical trials in migraine therapy | Q39680826 |
| | Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine | Q40584574 |
| | Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache | Q42168913 |
| | Migraine prevalence, disease burden, and the need for preventive therapy | Q43983035 |
| | Topiramate for migraine prevention: a randomized controlled trial | Q44776025 |
| | Topiramate in migraine prevention: results of a large controlled trial | Q44850997 |
| | Burden of migraine in the United States: disability and economic costs. | Q50644584 |
| | Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. | Q51120904 |
| | Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. | Q51756573 |
| | Chronic frequent headache in the general population: prevalence and associated factors. | Q51776151 |
| | Chronic migraine is an earlier stage of transformed migraine in adults. | Q51924006 |
| | Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). | Q53524572 |
| | Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. | Q55043216 |
| | Chronic daily headache in adolescents: Prevalence, impact, and medication overuse | Q57665815 |
| | Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors | Q57665872 |
| | Classification of daily and near-daily headaches: field trial of revised IHS criteria | Q71656653 |
| | Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up | Q73433308 |
| | The economic impact of migraine: an analysis of direct and indirect costs | Q74587632 |
| | Assessing the ability of topiramate to improve the daily activities of patients with migraine | Q79228488 |
| | Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials | Q79918801 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 18-30 | |
| P577 | publication date | 2010-05-17 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study | |
| P478 | volume | 31 | |